EndoChoice sells Fuse system in Georgia, Senate Finance Committee finds Gilead Sciences out for profit over patient care & more – 4 GI/endoscopy company key notes

Here are four recent news updates on gastroenterology and endoscopy companies.

Tifton (Ga.) Endoscopy Center acquired the Fuse Endoscopy Center from EndoChoice.

The Senate Finance Committee released a 144-page report on its findings from an 18-month, bipartisan investigation on the pricing and marketing of Gilead Sciences' hepatitis C drugs. The report concludes Gilead Sciences' primary concern was maximizing revenue, while affordability was not a focus.

Takeda Pharmaceutical and Cour Pharmaceutical Development entered into a partnership to research and develop immune modulating therapies for the treatment of celiac disease.

A new clinical study of the NuQ blood test from VolitionRx revealed the test was able to accurately detect 91 percent of colorectal cancer cases.

If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast